On the other hand, previous studies have shown that circulating levels of FGF-21 are increased in pathologies such as obesity, metabolic syndrome, insulin resistance, cardiovascular disease and different chronic inflammatory processes [61]. This evidence concerns the gene FGF21 and Obesity.